Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POTS: Treatment of Pediatric OCD
NCT00000384Phase 3Completed
- Sponsor
- University of Pennsylvania
- Start
- May 1997
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sertraline in obsessive compulsive disorder (OCD), sponsored by University of Pennsylvania. Started May 1997; status: completed.
02
Drugs
sertraline
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT00000384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000384.